662
Views
25
CrossRef citations to date
0
Altmetric
Reviews

Assessment of in silico models for fraction of unbound drug in human liver microsomes

, PhD (Associate Research Fellow) , , PhD (Associate Research Fellow) , , PhD (Principal Scientist) & , PhD (Senior Principal Scientist)
Pages 533-542 | Published online: 16 Mar 2010
 

Abstract

Importance of the field: Fraction of unbound drug in human liver microsome (fumic) incubation media is an important parameter for accurate assessment of hepatic intrinsic clearance and drug–drug interactions. In recent years, there have been considerable advances in understanding structure–microsomal binding relationships.

Areas covered in the review: This review highlights the in silico modeling techniques for fumic including physicochemical properties-based modeling, pharmacophore feature-based classification modeling and more complex statistical method-based modeling. The application of these modeling techniques to the understanding of the structure-binding relationships is also discussed.

What the reader will gain: The reader will gain an understanding of the modeling techniques used for prediction of binding to human liver microsomes (fumic). The reader will also understand the molecular structure–microsomal protein binding relationships. In all of these models, lipophilicity is the most important molecular property underlying the structure-binding relationship. Other molecular properties such as charge type (positive vs negative) and hydrogen bonding are also important factors for microsomal binding.

Take home message: The predictive accuracy of fumic models in the high lipophilicity and tight microsomal binding ranges still needs to be further improved. However, in silico models are still valuable tools to aid chemical library design and prioritize multiple chemical series, which could provide efficiency and decrease knowledge cycle times in drug discovery.

Notes

This box summarizes key points contained in the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.